Literature DB >> 17061036

The role of ATM in breast cancer development.

Jana Prokopcova1, Zdenek Kleibl, Claire M Banwell, Petr Pohlreich.   

Abstract

Complete or partial inability to sense and repair DNA damage increases the risk of developing cancer. The ataxia telangiectasia mutated (ATM) protein kinase has a crucial role in response to DNA double-strand breaks. Hereditary mutations in the ATM gene are the cause of a rare genomic instability syndrome ataxia telangiectasia (AT) characterized, among others, by elevated cancer risk. Although clear in homozygotes, numerous studies have failed to find a link between heterozygotes and cancer. However, there is increasing evidence that ATM heterozygotes have an increased risk of developing breast cancer. First, epidemiological studies conferred an increased risk of breast cancer among AT relatives. Second, in vitro studies of heterozygous cells provide strong evidence of hyperradiosensitivity. Third, some clinical studies found an increased frequency of ATM mutations among high-risk breast cancer families.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17061036     DOI: 10.1007/s10549-006-9406-6

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  22 in total

1.  Characterisation of ATM mutations in Slavic Ataxia telangiectasia patients.

Authors:  Jana Soukupova; Petr Pohlreich; Eva Seemanova
Journal:  Neuromolecular Med       Date:  2011-08-11       Impact factor: 3.843

2.  A right atrium metastasis of breast cancer after long-term endocrine therapy.

Authors:  Fengrui Xu; Xiaodi Wang; Zefei Jiang
Journal:  Ann Transl Med       Date:  2019-11

Review 3.  Genetic determinants at the interface of cancer and neurodegenerative disease.

Authors:  L G T Morris; S Veeriah; T A Chan
Journal:  Oncogene       Date:  2010-04-26       Impact factor: 9.867

4.  DNA repair gene polymorphisms and risk of pancreatic cancer.

Authors:  Donghui Li; Hideo Suzuki; Bingrong Liu; Jeffrey Morris; Jun Liu; Taro Okazaki; Yanan Li; Ping Chang; James L Abbruzzese
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

5.  ATM mutations in patients with hereditary pancreatic cancer.

Authors:  Nicholas J Roberts; Yuchen Jiao; Jun Yu; Levy Kopelovich; Gloria M Petersen; Melissa L Bondy; Steven Gallinger; Ann G Schwartz; Sapna Syngal; Michele L Cote; Jennifer Axilbund; Richard Schulick; Syed Z Ali; James R Eshleman; Victor E Velculescu; Michael Goggins; Bert Vogelstein; Nickolas Papadopoulos; Ralph H Hruban; Kenneth W Kinzler; Alison P Klein
Journal:  Cancer Discov       Date:  2011-12-29       Impact factor: 39.397

6.  Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer.

Authors:  M Schrauder; S Frank; P L Strissel; M P Lux; M R Bani; C Rauh; C C Sieber; K Heusinger; A Hartmann; R Schulz-Wendtland; R Strick; M W Beckmann; Peter A Fasching
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-09       Impact factor: 4.553

Review 7.  Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer.

Authors:  Nicholas J Roberts; Alison P Klein
Journal:  Cancer Lett       Date:  2012-11-27       Impact factor: 8.679

8.  Tumor protein D52 represents a negative regulator of ATM protein levels.

Authors:  Yuyan Chen; Alvin Kamili; Jayne R Hardy; Guy E Groblewski; Kum Kum Khanna; Jennifer A Byrne
Journal:  Cell Cycle       Date:  2013-08-21       Impact factor: 4.534

9.  Recent progress in mouse models for tumor suppressor genes and its implications in human cancer.

Authors:  Kazushi Inoue; Elizabeth A Fry; Pankaj Taneja
Journal:  Clin Med Insights Oncol       Date:  2013-06-03

10.  Variation of ATM Gene Expression in Peripheral Blood Cells of Sporadic Breast Carcinomas in Iranian Patients.

Authors:  Mohsen Foroughizadeh; Hossein Mozdarani; Keyvan Majidzadeh-A; Ahmad Kaviani
Journal:  Avicenna J Med Biotechnol       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.